Can a chatbot help prevent opioid overdoses? new pilot study explores telehealth solution

NCT ID NCT05832879

Completed Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a telehealth platform designed to encourage people with opioid use disorder to start and stay on medication treatment. 33 participants with a history of opioid overdose used the platform, which included chat-based support. The study measured whether they attended their first medication appointment and stayed engaged over 90 days, as well as tracking any further overdose events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telehealth platform (behavioral intervention)
What this could lead to: If successful, this could provide a scalable way to connect people with opioid use disorder to medication treatment and reduce overdose events.
What could go wrong: This is a small pilot study with only 33 participants, so results may not apply broadly. The platform's effectiveness depends on user engagement and access to technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Harm Reduction opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

Yale School of Medicine

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.